Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 7, 2023
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
[ Tue, Mar 07th 2023
] - WOPRAI
Anupam Rama Maintained (SNDX) at Buy with Decreased Target to $36 on, Mar 7th, 2023
Anupam Rama of JP Morgan, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Buy with Decreased Target from $41 to $36 on, Mar 7th, 2023.
Anupam has made no other calls on SNDX in the last 4 months.
There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Anupam
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $32 on, Thursday, March 2nd, 2023
- Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $33 on, Wednesday, March 1st, 2023
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $34 on, Wednesday, March 1st, 2023
- Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $37 on, Tuesday, January 31st, 2023
